A number of established ACC patient-derived-xenografts (ACCX) are readily available [18,19], however, the lack of validated ACC cell lines, harboring the t(6;9) translocation, has limited studies to unravel the functional aspect of MYB-NFIB fusion in ACC. The gene discussed is MYB; the disease is adrenal cortex carcinoma.